Investor Presentation • Nov 9, 2023
Investor Presentation
Open in ViewerOpens in native device viewer
9 November 2023
CEO - Paul de la Guérivière CFO - Nicolas de Kerangal
This Presentation and its appendices (the "Presentation") has been produced by BW Ideol AS (the "Company", and together with its direct and indirect subsidiaries, the "Group") solely for information purposes. This Presentation, and the information contained herein, does not constitute or form part of, and is not prepared or made in connection with, an offer or invitation to sell, or any solicitation of any offer to subscribe for or purchase any securities of the Company and nothing contained herein shall form the basis of any contract or commitment whatsoever. By attending a meeting where this Presentation is made, or by reading the Presentation slides or by otherwise receiving this Presentation or the information contained herein, you agree to be bound by the following terms, conditions and limitations. Any failure to comply with the restrictions set out herein may constitute a violation of applicable securities laws or may result in civil, administrative or criminal liabilities. For the purposes of this notice, "Presentation" means and includes this document and its appendices, any oral presentation given in connection with this Presentation, any question-and-answer session during or after such oral presentation and any written or oral material discussed or distributed during any oral presentation meeting. No representation, warranty or undertaking, express or implied, is made by the Company, its affiliates or representatives as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or the opinions contained herein, for any purpose whatsoever. Neither the Company nor any of its affiliates or representatives shall have any responsibility or liability whatsoever (for negligence or otherwise) for any loss whatsoever and howsoever arising from any use of this Presentation or its contents or otherwise arising in connection with this Presentation.
This Presentation speaks as of the date hereof. All information in this Presentation is subject to updating, revision, verification, correction, completion, amendment and may change materially and without notice. None of the Company, its affiliates or representatives undertakes any obligation to provide the recipient with access to any additional information or to update this Presentation or any information or to correct any inaccuracies in any such information. The information contained in this Presentation should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to reflect developments that may occur after the date of this Presentation. These materials do not purport to contain a complete description of the Group or the market(s) in which the Group operates, nor do they provide an audited valuation of the Group. The analyses contained in these materials are not, and do not purport to be, appraisals of the assets, stock or business of the Group or any other person. Moreover, these materials are incomplete without reference to, and should be viewed and considered solely in conjunction with, the oral briefing provided by an authorised representative of the Company in relation to these materials. The Company have not authorised any other person to provide any persons with any other information related to the Group and the Company will not assume any responsibility for any information other persons may provide.
The contents of this Presentation are not to be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should consult with its own financial, legal, business, investment and tax advisers to receive financial, legal, business, investment and tax advice. In particular, nothing herein shall be taken as constituting the giving of investment advice and these materials are not intended to provide, and must not be taken as, the exclusive basis of any investment decision or other valuation and should not be considered as a recommendation by the Company (or any of their affiliates) that any recipient enters into any transaction. These materials comprise a general summary of certain matters in connection with the Group. These materials do not purport to contain all of the information that any recipient may require to make a decision with regards to any transaction. Any decision as to whether or not to enter into any transaction should be taken solely by the relevant Recipient. Before entering into such transaction, each recipient should take steps to ensure that it fully understands such transaction and has made an independent assessments of the appropriateness of such transaction in the light of its own objectives and circumstances, including the possible risks and benefits of entering into such transaction.
This Presentation contains forward-looking information and statements relating to the business, financial performance and results of the Group and/or industry and markets in which it operates. Forward-looking statements are statements that are not historical facts and may be identified by words such as "aims", "anticipates", "believes", "estimates", "expects", "foresees", "intends", "plans", "predicts", "projects", "targets", and similar expressions. Such forward-looking statements are based on current expectations, estimates and projections, reflect current views with respect to future events, and are subject to risks, uncertainties and assumptions. Forward-looking statements are not guarantees of future performance and risks, uncertainties and other important factors could cause the actual results of operations, financial condition and liquidity of the Group or the industry to differ materially from this results expressed or implied in this Presentation by such forward-looking statements. No representation is made that any of these forward-looking statements or forecasts will come to pass or that any forecast result will be achieved and you are cautioned not to place any undue influence on any forward-looking statement.
The recipient acknowledges and accepts that it will be solely responsible for its own assessment of the Group, the market, the Group's market position, the Group's funding position, and the potential future performance of the Group's business and the Company's shares. The Company's shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or with any securities regulatory authority of any state or other jurisdiction in the United States, and may not be offered, sold, resold, pledged, delivered, distributed or transferred, directly or indirectly, into or within the United States, absent registration under the U.S. Securities Act or under an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act or in compliance with any applicable securities laws of any state or jurisdiction of the United States. Accordingly, any offer or sale of securities will only be offered or sold (i) within the United States or to U.S. Persons, only to qualified institutional buyers as defined under Rule 144A under the Securities Act ("QIBs") in offering transactions not involving a public offering and (ii) outside the United States in offshore transactions in accordance with Regulation S. Any purchaser of securities in the United States, or to or for the account of U.S. Persons, will be deemed to have been made certain representations and acknowledgements, including without limitation that the purchaser is a QIB.
The Company has not authorized any offer to the public of securities, or has undertaken or plans to undertake any action to make an offer of securities to the public requiring the publication of an offering prospectus, in any member state of the European Economic Area. No prospectus has or will be prepared in connection with this Presentation and the information contained herein. This Presentation is only addressed to and directed at persons in member states of the European Economic Area who are "qualified investors" within the meaning of Article 2 (E) of the Prospectus Regulation (Regulation (EU) 2017/1129).
Neither this Presentation nor the information contained herein is being issued, and nor may this Presentation nor the information contained herein be distributed, directly or indirectly, to or into any jurisdiction in which such issuance and/or distribution would be unlawful.
By accepting these materials, each recipient represents and warrants that it is able to receive them without contravention of an unfulfilled registration requirements or other legal or regulatory restrictions in the jurisdiction in which such recipients resides or conducts business. This Presentation is subject to and governed by Norwegian law, and any dispute arising in respect of this Presentation is subject to the exclusive jurisdiction of Norwegian courts with Oslo District Court as exclusive legal venue.

Development portfolio (GW)

Substantiated pipeline: projects with agreements signed by BW Ideol for a specific site or tender with leading partners
Opportunity pipeline: tenders announced by Governments with timing and capacity over the next 3 years

Voluntary offer Financing Operations and projects Financials & Outlook Q&A




Offer period is expected to commence on or about 09:00 (CET) on 14 November 2023 and end at 16:30 (CET) on 28 November 2023.

Voluntary offer Financing Operations and projects Financials & Outlook Q&A




• Covering project origination, tendering and commercial development activities, portfolio management to be entered between BW Ideol Projects Company and Ideol France for around EUR 3 million / year

Financing Operations and projects Financials & Outlook Q&A









Market Financing Operations and projects Financials & Outlook Q&A


| Net operating cash burn of EUR 5.2 million YTD 2023



| Continue to leverage unique and pioneering track-record, skills and competences, proprietary technology to establish floating wind leadership as a private company
| Focus on mid-term EPCI opportunities and selective progress co-development activities
| Maturing existing projects under development to reach key milestones and trigger value creation
| Backed by committed long-term owners as a private company following completion of recommended voluntary offer
1,0 3.7
Development portfolio (GW)
Under development H1 2023 Substantiated pipeline 2030 ambition

10,0



| Q3 2023 |
2023 H1 |
2022 FY |
|
|---|---|---|---|
| from with Revenue Contracts Customers |
404 | 1 971 |
6 639 |
| Other operating income |
336 | 652 | 2 106 |
| Operating expenses |
(2 595) |
(6 102) |
(11 488) |
| /(loss) depreciation/amortisation profit before Operating |
(1 856) |
(3 479) |
(2 743) |
| Depreciation | (2 184) |
(4 770) |
(9 510) |
| Amortisation | (1 181) |
(2 363) |
(4 387) |
| profit/(loss) Operating |
(5 221) |
(10 612) |
(16 641) |
| income Interest |
43 | 82 | 121 |
| Net Interest expense |
(148) | (80) | (106) |
| Other financial items |
8 | (178) | (814) |
| income/(expense) financial Net |
(98) | (176) | (799) |
| profit/(loss) Share of from accounted equity investments |
(62) | (97) | (57) |
| Profit/(loss) before tax |
(5 381) |
(10 886) |
(17 497) |
| Income tax expense |
210 | 432 | 869 |
| Profit/(loss) from continuing operations |
(5 171) |
(10 452) |
(16 628) |
| profit/(loss) for the period Net |
(5 171) |
(10 452) |
(16 628) |
| Attributable shareholder's of the to parent |
(5 171) |
(10 452) |
(16 628) |
| Attributable controlling interests to non |
- | - | - |

| Q3 2023 |
Q2 2023 |
YE 2022 |
|
|---|---|---|---|
| Other , plant & equipment Property |
457 | 500 | 530 |
| Right-of-use assets |
3 687 |
4 233 |
5 326 |
| Technical Installations |
2 | 1 597 |
5 187 |
| Other Intangible assets |
3 997 |
3 944 |
3 913 |
| Goodwill | 25 606 |
25 606 |
25 606 |
| Technology Asset |
49 632 |
50 628 |
52 620 |
| Subsidiary in Investment |
20 598 |
19 085 |
16 032 |
| Other non-current assets |
6 887 |
6 546 |
5 858 |
| Total non-current assets |
110 867 |
112 139 |
115 073 |
| Trade receivables and other current assets |
962 | 3 338 |
2 127 |
| Cash and cash equivalents |
1 992 |
5 941 |
9 133 |
| Total current assets |
2 954 |
9 279 |
11 260 |
| TOTAL ASSETS |
113 820 |
121 418 |
126 332 |

| Q3 2023 |
Q2 2023 |
2022 YE |
|
|---|---|---|---|
| Share Capital |
313 | 313 | 313 |
| Share Premium |
130 591 |
130 591 |
130 591 |
| Other Equity |
(32 916) |
(32 938) |
(16 389) |
| Retained Earnings |
(15 625) |
(10 453) |
(16 628) |
| Translation Foreign Currency Reserve |
80 | 250 | (5) |
| Total equity |
82 443 |
87 762 |
97 881 |
| Interest-bearing long-term debt |
3 143 |
3 203 |
4 229 |
| Shareholder loans |
5 000 |
5 000 |
|
| obligations Pension |
176 | 176 | 176 |
| retirement obligations Asset |
2 393 |
2 393 |
2 393 |
| Other long-term liabilities |
3 442 |
3 442 |
3 349 |
| lease liabilities Long-term |
1 609 0 , |
1 667 |
1 784 |
| Deferred Liability Tax |
10 919 |
11 138 |
11 576 |
| Total liabilities non-current |
26 681 |
27 019 |
23 507 |
| Trade payables and other short-term liabilities |
2 796 |
4 746 |
3 064 |
| Interest-bearing short-term debt |
1 654 |
1 654 |
1 650 |
| Short-term lease liabilities |
232 | 231 | 229 |
| liabilities Income tax |
14 | 5 | 1 |
| Total liabilities current |
4 696 |
6 636 |
4 944 |
| Total liabilities |
31 377 |
33 656 |
28 451 |
| TOTAL EQUITY AND LIABILITIES |
113 820 |
121 418 |
126 332 |

| Q3 2023 | H1 2023 | FY 2022 | |
|---|---|---|---|
| Profit/(loss) before taxes | (5 381) | (10 886) | (17 497) |
| Unrealised currency exchange loss/(gain) | (25) | 140 | 730 |
| Depreciation and amortisation | 3 365 | 7 133 | 13 897 |
| Share-based payment expense | 22 | 85 | 626 |
| Change in Subsidies & Grants Receivable | (336) | (647) | (319) |
| Add back of net interest expense | 106 | (1) | (15) |
| Changes in working capital | 586 | 674 | (868) |
| Net cash flow from operating activities | (1 663) | (3 501) | (3 445) |
| Investment in other property, plant & equipment | - | (57) | (519) |
| Investment in other intangible assets (capitalized R&D) | (266) | (458) | (942) |
| Investments in financial investments | - | - | (493) |
| Investments in joint ventures | (1 744) | (2 874) | (16 753) |
| Net cash flow from investing activities | (2 010) | (3 389) | (18 707) |
| Shareholder Loan | - | 5 000 | - |
| Repayment of debt and other liabilities | (189) | (1 127) | (1 160) |
| Interest paid | (22) | (44) | (105) |
| Payment of lease liabilities | (65) | (130) | (242) |
| Net cash flow from financing activities | (276) | 3 698 | (1 507) |
| Net change in cash and cash equivalents | (3 949) | (3 192) | (23 659) |
| Cash and cash equivalents at beginning of period | 5 941 | 9 133 | 32 792 |
| Cash and cash equivalents at end of period | 1 992 | 5 941 | 9 133 |

Contact : Nicolas de Kerangal, CFO [email protected] + 33 (0)7 76 87 70 08


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.